Benefits for children with suspected cancer from routine whole-genome sequencing

4Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Clinical whole-genome sequencing (WGS) has been shown to deliver potential benefits to children with cancer and to alter treatment in high-risk patient groups. It remains unknown whether offering WGS to every child with suspected cancer can change patient management. We collected WGS variant calls and clinical and diagnostic information from 281 children (282 tumors) across two English units (n = 152 from a hematology center, n = 130 from a solid tumor center) where WGS had become a routine test. Our key finding was that variants uniquely attributable to WGS changed the management in ~7% (20 out of 282) of cases while providing additional disease-relevant findings, beyond standard-of-care molecular tests, in 108 instances for 83 (29%) cases. Furthermore, WGS faithfully reproduced every standard-of-care molecular test (n = 738) and revealed several previously unknown genomic features of childhood tumors. We show that WGS can be delivered as part of routine clinical care to children with suspected cancer and can change clinical management by delivering unexpected genomic insights. Our experience portrays WGS as a clinically impactful assay for routine practice, providing opportunities for assay consolidation and for delivery of molecularly informed patient care.

References Powered by Scopus

Genomic classification and prognosis in acute myeloid leukemia

3160Citations
N/AReaders
Get full text

COSMIC: The Catalogue Of Somatic Mutations In Cancer

3056Citations
N/AReaders
Get full text

Pan-cancer analysis of whole genomes

1868Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The economic costs of precision medicine for clinical translational research among children with high-risk cancer

1Citations
N/AReaders
Get full text

Developing a Paired Whole Genome Sequencing Service for Children With Cancer

0Citations
N/AReaders
Get full text

A diagnosis of Noonan syndrome through routine whole genome sequencing in a child with an intracranial nongerminomatous germ cell tumor

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Hodder, A., Leiter, S. M., Kennedy, J., Addy, D., Ahmed, M., Ajithkumar, T., … Behjati, S. (2024). Benefits for children with suspected cancer from routine whole-genome sequencing. Nature Medicine, 30(7), 1905–1912. https://doi.org/10.1038/s41591-024-03056-w

Readers over time

‘24‘2509182736

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 8

47%

Researcher 7

41%

Professor / Associate Prof. 2

12%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 5

36%

Medicine and Dentistry 4

29%

Agricultural and Biological Sciences 3

21%

Neuroscience 2

14%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1
News Mentions: 18
Social Media
Shares, Likes & Comments: 23

Save time finding and organizing research with Mendeley

Sign up for free
0